|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/10 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 9/08 | (2006.01) |
| (11) | Number of the document | 2821407 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14185954.6 |
| Date of filing the European patent application | 2011-11-10 | |
| (97) | Date of publication of the European application | 2015-01-07 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation | 2016-12-12 |
| (30) | Number | Date | Country code |
| 413077 P | 2010-11-12 | US | |
| 201061425034 P | 2010-12-20 | US |
| (72) |
Bell, Ian, M., US
Fraley, Mark, E., US
Gallicchio, Steven, N., US
Ginnetti, Anthony, US
Mitchell, Helen, J., US
Paone, Daniel, V, US
Staas, Donnette, D, US
Wang, Cheng, US
Zartman, C. Blair, US
Stevenson, Heather, E., US
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Piperidinono karboksamido azaindano CGRP receptoriaus antagonistai |
| PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-10-14 | 15 | 289.00 EUR |
| 2026-11-10 |